Skip to content
EyePoint Homepage
Contact Us
  • About
  • Technology
  • Pipeline
  • Products
    • YUTIQ
    • DEXYCU
  • Investors
  • News
  • Careers
  • About
  • Technology
  • Pipeline
  • Products
    • YUTIQ
    • DEXYCU
  • Investors
  • News
  • Careers
EyePoint Homepage
  • Home
  • About
  • Technology
  • Pipeline
  • Products
    • YUTIQ
    • DEXYCU
  • Investors
  • News
  • Careers
  • Contact
Menu
  • Home
  • About
  • Technology
  • Pipeline
  • Products
    • YUTIQ
    • DEXYCU
  • Investors
  • News
  • Careers
  • Contact

Sitemap

Home

About

Technology

Products

YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg
DEXYCU® (dexamethasone intraocular suspension) 9%

Pipeline

Investors

News

Contact Us

Careers

Terms and Conditions

Privacy Policy

Patent Notification

  • Home
  • About
  • Technology
  • Products
  • Pipeline
  • Investors
  • Contact Us
  • News
  • Careers
  • Sitemap
  • Terms and Conditions
  • Privacy Policy
  • Patent Notification
  • Home
  • About
  • Technology
  • Products
  • Pipeline
  • Investors
  • Contact Us
  • News
  • Careers
  • Sitemap
  • Terms and Conditions
  • Privacy Policy
  • Patent Notification
EyePoint Homepage

EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. With an Eye on Patients is a trademark of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, and Delivering Innovation to the Eye are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, YUTIQ, Durasert, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc. Verisome is a registered trademark of Ramscor, Inc. All other trademarks are the property of their respective owners.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, YUTIQ, and Durasert are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, the YUTIQ logo, and the DEXYCU logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, YUTIQ, the YUTIQ logo, and Durasert are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, DEXYCU, and the DEXYCU logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, Durasert, YUTIQ, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

EyePoint, the EyePoint logo, YUTIQ, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.

04/2021
US-EYP-2100003

Linkedin Facebook Twitter